Niagen Bioscience, Inc. SEC filings NAGE
Niagen Bioscience, Inc. has 981 filings in SEC EDGAR's recent list, going back to Jan 18, 2007. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 9, 2026 | — |
| EFFECT | Filing | Jul 5, 2023 | — |
| CORRESP | Letter to the SEC | Jun 30, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2023 | — |
| EFFECT | Filing | Nov 16, 2022 | — |
| CORRESP | Letter to the SEC | Nov 14, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 9, 2022 | — |
| D | Filing | Oct 14, 2022 | — |
| CT ORDER | Filing | Sep 7, 2022 | — |
| EFFECT | Filing | Apr 22, 2021 | — |
| CORRESP | Letter to the SEC | Apr 21, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2021 | — |
| D | Filing | Mar 3, 2021 | — |
| CT ORDER | Filing | Oct 28, 2020 | — |
| CT ORDER | Filing | Sep 11, 2020 | — |
| CT ORDER | Filing | Aug 17, 2020 | — |
| EFFECT | Filing | Jun 26, 2020 | — |
| CORRESP | Letter to the SEC | Jun 24, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2020 | — |
| EFFECT | Filing | Jun 1, 2020 | — |
| UPLOAD | Letter from the SEC | May 28, 2020 | — |
| CORRESP | Letter to the SEC | May 28, 2020 | — |
| CT ORDER | Filing | May 26, 2020 | — |
| D | Filing | May 20, 2020 | — |
| NT 10-Q | Nt 10q | May 12, 2020 | Mar 31, 2020 |
| CT ORDER | Filing | Apr 2, 2020 | — |
| CT ORDER | Filing | Mar 24, 2020 | — |
| CT ORDER | Filing | Mar 24, 2020 | — |
| CT ORDER | Filing | Mar 19, 2020 | — |
| CT ORDER | Filing | Oct 24, 2019 | — |
| CT ORDER | Filing | Oct 24, 2019 | — |
| EFFECT | Filing | Oct 2, 2019 | — |
| CORRESP | Letter to the SEC | Sep 30, 2019 | — |
| CORRESP | Letter to the SEC | Sep 26, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2019 | — |
| D | Filing | Aug 29, 2019 | — |
| CT ORDER | Filing | Jun 4, 2019 | — |
| D | Filing | May 24, 2019 | — |
| CT ORDER | Filing | Mar 18, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2019 | — |
| CORRESP | Letter to the SEC | Dec 26, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2018 | — |
| EFFECT | Filing | Dec 29, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2017 | — |
| CORRESP | Letter to the SEC | Dec 27, 2017 | — |
| CT ORDER | Filing | Dec 22, 2017 | — |
| CT ORDER | Filing | Dec 5, 2017 | — |
| D | Filing | Nov 29, 2017 | — |
| EFFECT | Filing | Nov 8, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2017 | — |
| CORRESP | Letter to the SEC | Nov 6, 2017 | — |
| CT ORDER | Filing | Oct 12, 2017 | — |
| D | Filing | Aug 31, 2017 | — |
| EFFECT | Filing | Jun 21, 2017 | — |
| CORRESP | Letter to the SEC | Jun 19, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2017 | — |
| D | Filing | Jun 6, 2017 | — |
| D | Filing | May 5, 2017 | — |
| D | Filing | Mar 22, 2017 | — |
| CT ORDER | Filing | Dec 22, 2016 | — |
| CT ORDER | Filing | Nov 8, 2016 | — |
| CT ORDER | Filing | Jun 7, 2016 | — |
| CERTNAS | Auto-generated paper document | Apr 22, 2016 | — |
| 8-A12B | Form 8-a | Apr 21, 2016 | — |
| D | Filing | Mar 16, 2016 | — |
| CT ORDER | Filing | Feb 5, 2016 | — |
| CT ORDER | Filing | Dec 17, 2015 | — |
| EFFECT | Filing | Jun 5, 2015 | — |
| CORRESP | Letter to the SEC | Jun 2, 2015 | — |
| CT ORDER | Filing | May 5, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2015 | — |
| CT ORDER | Filing | Mar 4, 2015 | — |
| CT ORDER | Filing | Mar 4, 2015 | — |
| CT ORDER | Filing | Jan 5, 2015 | — |
| D | Filing | Oct 14, 2014 | — |
| CT ORDER | Filing | Jun 20, 2014 | — |
| CT ORDER | Filing | Dec 13, 2013 | — |
| NT 10-Q | This is a nt 10-q attachment file in htm format. | Nov 12, 2013 | Sep 28, 2013 |
| D | Filing | Oct 24, 2013 | — |
| CT ORDER | Filing | May 28, 2013 | — |
| EFFECT | Filing | May 9, 2012 | — |
| D | Filing | Feb 22, 2012 | — |
| CT ORDER | Filing | Dec 9, 2011 | — |
| EFFECT | Filing | Oct 19, 2011 | — |
| CORRESP | Letter to the SEC | Oct 18, 2011 | — |
| CT ORDER | Filing | Oct 14, 2011 | — |
| CORRESP | Letter to the SEC | Sep 26, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2011 | — |
| CORRESP | Letter to the SEC | Sep 12, 2011 | — |
| CORRESP | Letter to the SEC | Sep 8, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2011 | — |
| EFFECT | Filing | Mar 24, 2011 | — |
| EFFECT | Filing | Sep 16, 2010 | — |
| CORRESP | Letter to the SEC | Sep 15, 2010 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2010 | — |
| CT ORDER | Filing | Jun 21, 2010 | — |
| D | Filing | May 27, 2010 | — |
| CT ORDER | Filing | Sep 22, 2008 | — |
| REGDEX | Auto-generated paper document | Aug 4, 2008 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2008 | — |
| REGDEX | Auto-generated paper document | Jun 30, 2008 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2008 | — |
| 8-A12G | Form 8-a | Jun 25, 2008 | — |
| 10QSB | Mainbody | Apr 16, 2008 | Dec 31, 2007 |
| NT 10-Q | Mainbody | Apr 14, 2008 | Feb 29, 2008 |
| 10KSB | Mainbody | Feb 20, 2008 | Nov 30, 2007 |
| 10QSB | Mainbody | Oct 15, 2007 | Aug 31, 2007 |
| 10QSB | Mainbody | Jul 20, 2007 | May 31, 2007 |
| NT 10-Q | Mainbody | Jul 13, 2007 | May 31, 2007 |
| 10QSB | Mainbody | Apr 17, 2007 | Feb 28, 2007 |
| NT 10-Q | Mainbody | Apr 16, 2007 | Feb 28, 2007 |
| REGDEX | Auto-generated paper document | Feb 7, 2007 | — |
| EFFECT | Filing | Feb 2, 2007 | — |
| SB-2 | Mainbody | Jan 18, 2007 | — |
Showing 115 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NAGE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1386570
- Former names
- ChromaDex Corp. (until Mar 10, 2025); CODY RESOURCES, INC. (until Jun 24, 2008)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.